Vosoritide para acondroplasia con epífisis abierta
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1397008

Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-bivalent-covid-19-vaccines

http://www.fda.gov/medical-devices/medical-device-recalls/jiangsu-well-biotech-co-ltd-recalls-covid-19-ag-rapid-test-devices-are-not-authorized-cleared-or

FDA Roundup: October 11, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-11-2022

FDA Roundup: October 7, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-7-2022

FDA Approves Vaccine for Use During Third Trimester of Pregnancy to Prevent Whooping Cough in Infants Younger Than Two Months of Age
http://www.fda.gov/news-events/press-announcements/fda-approves-vaccine-use-during-third-trimester-pregnancy-prevent-whooping-cough-infants-younger-two

New Data Show More Than 2.5 Million U.S. Youth Currently Use E-Cigarettes
http://www.fda.gov/news-events/press-announcements/new-data-show-more-25-million-us-youth-currently-use-e-cigarettes

FDA Roundup: October 4, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-october-4-2022

FDA Roundup: September 30, 2022 
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-30-2022

FDA Pathway Supports Long-Term Stability, Diversity of Safe and Nutritious Infant Formula Supply in the U.S.
http://www.fda.gov/news-events/press-announcements/fda-pathway-supports-long-term-stability-diversity-safe-and-nutritious-infant-formula-supply-us